194 related articles for article (PubMed ID: 29458728)
1. Clinical Complications and Their Management.
Marcon A; Motta I; Taher AT; Cappellini MD
Hematol Oncol Clin North Am; 2018 Apr; 32(2):223-236. PubMed ID: 29458728
[TBL] [Abstract][Full Text] [Related]
2. Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.
Sleiman J; Tarhini A; Bou-Fakhredin R; Saliba AN; Cappellini MD; Taher AT
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316681
[TBL] [Abstract][Full Text] [Related]
3. Morbidities in non-transfusion-dependent thalassemia.
Saliba AN; Taher AT
Ann N Y Acad Sci; 2016 Mar; 1368(1):82-94. PubMed ID: 27186941
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability and Vascular Disease.
Taher AT; Cappellini MD; Bou-Fakhredin R; Coriu D; Musallam KM
Hematol Oncol Clin North Am; 2018 Apr; 32(2):237-245. PubMed ID: 29458729
[TBL] [Abstract][Full Text] [Related]
5. Iron overload in thalassemia: different organs at different rates.
Taher AT; Saliba AN
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):265-271. PubMed ID: 29222265
[TBL] [Abstract][Full Text] [Related]
6. Non-Transfusion-Dependent Thalassemia: A Panoramic Review.
Shash H
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295656
[TBL] [Abstract][Full Text] [Related]
7. Non-transfusion Dependent Thalassemias: A Developing Country Perspective.
Mukherjee S; Das RR; Raghuwanshi B
Curr Pediatr Rev; 2015; 11(2):87-97. PubMed ID: 26133180
[TBL] [Abstract][Full Text] [Related]
8. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management.
Vichinsky E
Curr Med Res Opin; 2016; 32(1):191-204. PubMed ID: 26479125
[TBL] [Abstract][Full Text] [Related]
9. Marital status and paternity in patients with Transfusion- Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries.
De Sanctis V; Soliman AT; El-Hakim I; Christou S; Mariannis D; Karimi M; Ladis V; Kattamis A; Daar S; Yassin M; Canatan D; Galati MC; Raiola G; Campisi S; Kakkar S; Kaleva V; Saki F; Ellinides A; Pikis G; Christodoulides C; Abdulla M; Di Maio S; Theodoridis C; Elsedfy H; Kattamis C
Acta Biomed; 2019 Sep; 90(3):225-237. PubMed ID: 31580308
[TBL] [Abstract][Full Text] [Related]
10. Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.
Taher AT; Temraz S; Cappellini MD
Expert Rev Hematol; 2013 Oct; 6(5):495-509. PubMed ID: 24083402
[TBL] [Abstract][Full Text] [Related]
11. [The endocrine complications in thalassemia major].
Anastasi S; Caruso V; Magnano C; Leocata A
Pediatr Med Chir; 1991; 13(1):63-5. PubMed ID: 2052458
[TBL] [Abstract][Full Text] [Related]
12. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
[TBL] [Abstract][Full Text] [Related]
13. Non-transfusion-dependent thalassemias.
Musallam KM; Rivella S; Vichinsky E; Rachmilewitz EA
Haematologica; 2013 Jun; 98(6):833-44. PubMed ID: 23729725
[TBL] [Abstract][Full Text] [Related]
14. Iron Chelation Therapy as a Modality of Management.
Aydinok Y
Hematol Oncol Clin North Am; 2018 Apr; 32(2):261-275. PubMed ID: 29458731
[TBL] [Abstract][Full Text] [Related]
15. EASL Clinical Practice Guidelines: Vascular diseases of the liver.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
J Hepatol; 2016 Jan; 64(1):179-202. PubMed ID: 26516032
[No Abstract] [Full Text] [Related]
16. Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron.
Inthawong K; Charoenkwan P; Silvilairat S; Tantiworawit A; Phrommintikul A; Choeyprasert W; Natesirinilkul R; Siwasomboon C; Visrutaratna P; Srichairatanakool S; Chattipakorn N; Sanguansermsri T
Hematology; 2015 Dec; 20(10):610-7. PubMed ID: 25964094
[TBL] [Abstract][Full Text] [Related]
17. Increasing prevalence of thalassemia in America: Implications for primary care.
Sayani FA; Kwiatkowski JL
Ann Med; 2015; 47(7):592-604. PubMed ID: 26541064
[TBL] [Abstract][Full Text] [Related]
18. Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand.
Chuncharunee S; Teawtrakul N; Siritanaratkul N; Chueamuangphan N
PLoS One; 2019; 14(3):e0214148. PubMed ID: 30893381
[TBL] [Abstract][Full Text] [Related]
19. Endocrine complications in transfusion dependent thalassaemia in Penang Hospital.
Ong CK; Lim SL; Tan WC; Ong EE; Goh AS
Med J Malaysia; 2008 Jun; 63(2):109-12. PubMed ID: 18942294
[TBL] [Abstract][Full Text] [Related]
20. Unmet needs in β-thalassemia and the evolving treatment landscape.
Njeim R; Naouss B; Bou-Fakhredin R; Haddad A; Taher A
Transfus Clin Biol; 2024 Feb; 31(1):48-55. PubMed ID: 38128605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
